Abstract: A medicament is disclosed for reducing the risk of cross-healing (“adhesions”) after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.
Type:
Grant
Filed:
August 10, 2000
Date of Patent:
April 13, 2004
Assignee:
Britannia Pharmaceuticals Ltd.
Inventors:
Brian Andrew Hills, Derek Alan Woodcock